ROLE OF BISPHOSPHONATES IN METABOLIC BONE-DISEASES

被引：9

作者：

HAMDY, NAT

机构：

[1] Neveen A.T. Hamdy is at the Department of Endocrinology and Metabolic Diseases, Leiden University Hospital, Leiden

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 1993年 / 4卷 / 01期

关键词：

D O I：

10.1016/1043-2760(93)90059-N

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption and represent the treatment of choice in disorders associated with accelerated bone resorption. They are widely used in the management of Paget's disease of bone and hypercalcemia of malignancy. Over the past few years, evidence has been accumulating for a beneficial effect of these agents in tumor-induced osteolytic bone disease and in established osteoporosis. Bisphosphonates may also play a useful though limited role in the medical management of hyperparathyroidism and heterotopic ossification.

引用

页码：19 / 25

页数：7

共 55 条

[1] THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].

ADAMI, S ;

BHALLA, AK ;

DORIZZI, R ;

MONTESANTI, F ;

ROSINI, S ;

SALVAGNO, G ;

LOCASCIO, V .

CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331

[2] PREVENTION OF ECTOPIC BONE-FORMATION BY LOCAL APPLICATION OF ETHANE-1-HYDROXY-1,1-DIPHOSPHONATE (EHDP) - AN EXPERIMENTAL-STUDY IN RABBITS [J].

AHRENGART, L ;

LINDGREN, U .

JOURNAL OF ORTHOPAEDIC RESEARCH, 1986, 4 (01) :18-26

[3] EFFECT OF A DIPHOSPHONATE ON PARA-ARTICULAR OSSIFICATION AFTER TOTAL HIP-REPLACEMENT [J].

BIJVOET, OLM ;

NOLLEN, AJG ;

SLOOFF, TJJ ;

FEITH, R .

ACTA ORTHOPAEDICA SCANDINAVICA, 1974, 45 (06) :926-934

[4] BONE AND RENAL COMPONENTS IN HYPERCALCEMIA OF MALIGNANCY AND RESPONSES TO A SINGLE INFUSION OF CLODRONATE [J].

BONJOUR, JP ;

PHILIPPE, J ;

GUELPA, G ;

BISETTI, A ;

RIZZOLI, R ;

JUNG, A ;

ROSINI, S ;

KANIS, JA .

BONE, 1988, 9 (03) :123-130

[5]

BOONEKAMP PM, 1986, BONE MINER, V1, P27

[6]

BURCKHARDT P, 1990, MANAGEMENT OF BONE METASTASES AND HYPERCALCAEMIA BY OSTEOCLAST INHIBITION, P30

[7]

CHAPUY MC, 1983, METAB BONE DIS RELAT, V4, P325

[8]

CHESNUT CH, 1984, OSTEOPOROSIS, P549

[9] LONG-TERM EFFECTS OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGETS-DISEASE OF BONE [J].

DELMAS, PD ;

CHAPUY, MC ;

VIGNON, E ;

CHARHON, S ;

BRIANCON, D ;

ALEXANDRE, C ;

EDOUARD, C ;

MEUNIER, PJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (04) :837-844

[10] LONG-TERM EFFECTS OF DICHLOROMETHYLENE DIPHOSPHONATE (CL2MDP) ON SKELETAL LESIONS IN MULTIPLE-MYELOMA [J].